Novartis Ordered To Pay $41M In Contact Lens Spat
A jury has said Novartis AG unit CIBA Vision Corp. must pay $41 million for allegedly violating a Rembrandt Vision Technologies LP patent for a treatment that allows users to wear...To view the full article, register now.
Already a subscriber? Click here to view full article